Cover Image
市場調查報告書

Polyresistin的中國市場:2010∼2019年

Market Research Report on Polyresistin in China, 2010-2019

出版商 China Research and Intelligence 商品編碼 353344
出版日期 內容資訊 英文 20 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Polyresistin的中國市場:2010∼2019年 Market Research Report on Polyresistin in China, 2010-2019
出版日期: 2016年02月29日 內容資訊: 英文 20 Pages
簡介

Polyresistin,具有提高人體的免疫力,控制腫瘤的成長、代謝這樣的作用,也提高對放射線的抗性,讓腫瘤患者能成為容易接受放射治療的狀態。還有也可用於白血球減少症和再生不良性貧血的治療,各種感染疾病的免疫力不全的預防等。中國國內Polyresistin也順利伸展銷售額,2014年為7000萬人民幣以下的市場規模,以17.7%年複合成長率 (CAGR) 成長,2016年達2億5000萬人民幣。中國由於迅速的經濟發展,環境破壞和生活習慣變化發展,癌症和呼吸疾病患者增多,一般認為Polyresistin市場今後將更加擴大。

本報告提供中國的Polyresistin的市場相關分析,Polyresistin的特徵和認證情形,整體市場規模,各企業、各劑型的市場佔有率,價格趨勢,主要製造商簡介,今後的市場成長預測等的調查評估在。

第1章 Polyresistin的相關概念

  • 適應症
  • 全球市場的銷售情形

第2章 中國國內的Polyresistin市場簡介

  • 中國國內的Polyresistin的專利申請、核準情況
  • 主要製造商
  • 市場規模

第3章 中國國內的Polyresistin銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 Polyresistin的主要廠商的市場佔有率 (過去5年份)

  • 主要廠商的市場佔有率 (以金額為準)
  • 主要廠商的市場佔有率 (以數量為準)

第5章 中國國內的Polyresistin的劑型 (過去5年份)

  • 各劑型的市場佔有率 (以金額為準)
  • 各劑型的市場佔有率 (以數量為準)

第6章 中國的醫院的Polyresistin的參照價格

  • Sinopharm A-Think Pharmaceutical Co., Ltd.
  • Chengdu Li'er Pharmaceutical Co., Ltd.
  • Sichuan Aobang Pharmaceutical Co., Ltd.
  • Guangdong Winnerway Pharmaceutical Co., Ltd.
  • Pearl Ocean Pharmaceutical Holdings, Ltd.

第7章 中國國內的Polyresistin的主要製造商 (過去5年份)

  • Sinopham A-Think Pharmaceutical Co., Ltd.
  • Chengdu Li'er Pharmaceutical Co., Ltd.
  • Sichuan Aobang Pharmaceutical Co., Ltd.
  • Guangdong Winnerway Pharmaceutical Co., Ltd.
  • Pearl Ocean Pharmaceutical Holdings, Ltd.

第8章 中國國內的Polyresistin市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭模式的預測

圖表一覽

目錄
Product Code: 1602323

Polyresistin refers to a kind of polysaccharides extracted from hemolytic streptococcus through fermenting. Polyresistin is a system of enhancing immune, which can inhibit the growth and metabolism of tumor cells, promote the growth of erythropoietin and enhance the reticuloendothelial system, activation of lymphocytes, which can strengthen and regulate immune function. It can also improve the body's stress function and enhance the body's non-specific resistance and have the function of anti-radiation damage, which can enhance the effect of radiation oncology.

Polyresistin primarily for the treatment of leukopenia, aplastic anemia; prevention of immune dysfunction caused by a variety of infections; with various types of cancer, radiotherapy, chemotherapy or adjuvant treatment after surgery, radiation injury prevention; at the same time with this product in infection allergic arthritis, recurrent respiratory infections, treatment of peptic ulcer, chronic atrophic gastritis, cervical erosion, oral mucosal disease and the like.

In recent years, Polyresistin keeps good sales in the Chinese market. According to the CRI's investigation on sample hospitals, the sales value of Polyresistin increased to CNY 250 million in 2014 from less than CNY 70 million in 2016, with CAGR of 17.7%.

With the aggravation of environmental pollution in China, as well as lifestyle changes brought about by economic development, China is expected to have an increasing incidence of cancer, respiratory tract infections in the future, which will facilitate enlarging the market size of Polyresistin.

Through this report, readers can learn the followings and more:

  • the market size of Polyresistin in China
  • the market competition pattern of Polyresistin in China
  • the sales price of Polyresistin produced by different enterprises in China
  • the outlook on Polyresistin market in China

The author recommends the following people to purchase this report:

  • immunomodulator manufacturing enterprise
  • Investors / research institutes focusing on Chinese drug market

If interested in Chinese pharmaceutical market, you can contact CRI for customized survey service.

Table of Contents

1. Related Concept of Polyresistin

  • 1.1. Indications
  • 1.2. Sales Status of Global Market

2. Market Overview of Polyresistin in China

  • 2.1. The Patent Status and Approval Information of Polyresistin in China
  • 2.2. The Main Producers
  • 2.3. Market Size

3. Inquiry on The Sales Status of Polyresistin in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Region
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Region

4. Inquiry on the Market Share of Chinese major Polyresistin Producers, 2010-2014

  • 4.1. Market Share of Producing Businesses by Sales Value
  • 4.2. Market Share of Producing Businesses by Sales Volume

5. Research on the Dosage of Polyresistin in China, 2010-2014

  • 5.1. Dosage Share by Sales Value
  • 5.2. Dosage Share by Sales Volume

6. The Reference Price of Polyresistin in Chinese Hospitals in 2014

  • 6.1. Sinopharm A-Think Pharmaceutical Co., Ltd.
  • 6.2. Chengdu Li'er Pharmaceutical Co., Ltd.
  • 6.3. Sichuan Aobang Pharmaceutical Co., Ltd.
  • 6.4. Guangdong Winnerway Pharmaceutical Co., Ltd.
  • 6.5. Pearl Ocean Pharmaceutical Holdings, Ltd.

7. The Main Producers of Polyresistin in the Chinese Market, 2010-2014

  • 7.1. Sinopham A-Think Pharmaceutical Co., Ltd.
  • 7.2. Chengdu Li'er Pharmaceutical Co., Ltd.
  • 7.3. Sichuan Aobang Pharmaceutical Co., Ltd.
  • 7.4. Guangdong Winnerway Pharmaceutical Co., Ltd.
  • 7.5. Pearl Ocean Pharmaceutical Holdings, Ltd.

8. Market Outlook of Polyresistin in China, 2015-2019

  • 8.1. Prediction of Market size
  • 8.2. Prediction of Competition Pattern

Part of the Table of Contents

  • Chart The Approval Information of Polyresistin in China
  • Chart The Sales Value of Polyresistin in China, 2010- 2014
  • Chart The Sales Value of Polyresistin in Parts of China, 2010-2014
  • Chart The Sales Volume of Aceglutamide in China, 2010-2014
  • Chart The Sales Volume of Polyresistin in Parts of China, 2010-2014
  • Chart The Market Share of Top 5 Sales Value of Polyresistin of Enterprises in China, 2010-2014
  • Chart The Sales Value and The Market Share of Polyresistin produced by Sinopharm A-Think Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Value and The Market Share of Polyresistin produced by Chengdu Li'er Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Value and The Market Share of Polyresistin produced by Guangdong Winnerway Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Value and The Market Share of Polyresistin produced by Qingdao Baiyang Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Value and The Market Share of Polyresistin produced by other corporations, 2010-2014
  • Chart The Market Share of Top 5 Sales Volume of Polyresistin of Enterprises in China, 2010-2014
  • Chart The Sales Volume and The Market Share of Polyresistin produced by Chengdu Li'er Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Volume and The Market Share of Polyresistin produced by Sinopharm A-Think Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Volume and The Market Share of Polyresistin produced by Sichuan Aobang Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Value and The Market Share of Polyresistin produced by Guangdong Winnerway Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart The Sales Price of Polyresistin produced by Sinopharm A-Think Pharmaceutical Co., Ltd in some cities of China in 2004
  • Chart The Sales Price of Polyresistin produced by Chengdu Li'er Pharmaceutical Co., Ltd in some cities of China in 2004
  • Chart The Sales Price of Polyresistin produced by Sichuan Aobang Pharmaceutical Co., Ltd in some cities of China in 2004
  • Chart The Sales Price of Polyresistin produced by Guangdong Winnerway Pharmaceutical Co., Ltd in some cities of China in 2004
  • Chart The Sales Price of Polyresistin produced by Qingdao Baiyang Pharmaceutical Co., Ltd in some cities of China in 2004
Back to Top